MedTrace Logo

Effect of Choline Fenofibrate (SLV348) on Macular Edema

NCT00683176 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2011-08-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of choline fenofibrate on the regression of macular edema in eyes of subjects with type 2 diabetes mellitus (T2DM) presenting with diabetic macular edema (DME)

Conditions

Interventions

DRUG

Choline Fenofibrate

135 mg

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Abbott Products

    lead INDUSTRY

Principal Investigators

  • Dr Jean-Claude Ansquer, MD · Abbott Products

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Bulgaria
  • Czechia
  • Denmark
  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00683176 on ClinicalTrials.gov